HCSGD entry for COL2A1
1. General information
Official gene symbol | COL2A1 |
---|---|
Entrez ID | 1280 |
Gene full name | collagen, type II, alpha 1 |
Other gene symbols | ANFH AOM COL11A3 SEDC |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network

This gene isn't in Literature mining network.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0001501 | Skeletal system development | IMP | biological_process |
GO:0001502 | Cartilage condensation | IEA | biological_process |
GO:0001894 | Tissue homeostasis | IEA | biological_process |
GO:0001958 | Endochondral ossification | IEA | biological_process |
GO:0002062 | Chondrocyte differentiation | IEA | biological_process |
GO:0003007 | Heart morphogenesis | IEA | biological_process |
GO:0005576 | Extracellular region | TAS | cellular_component |
GO:0005585 | Collagen type II | IDA | cellular_component |
GO:0005604 | Basement membrane | IEA | cellular_component |
GO:0005615 | Extracellular space | IEA | cellular_component |
GO:0005788 | Endoplasmic reticulum lumen | TAS | cellular_component |
GO:0006029 | Proteoglycan metabolic process | IEA | biological_process |
GO:0007411 | Axon guidance | TAS | biological_process |
GO:0007417 | Central nervous system development | IEA | biological_process |
GO:0007601 | Visual perception | IMP | biological_process |
GO:0007605 | Sensory perception of sound | IMP | biological_process |
GO:0010468 | Regulation of gene expression | IEA | biological_process |
GO:0022617 | Extracellular matrix disassembly | TAS | biological_process |
GO:0030020 | Extracellular matrix structural constituent conferring tensile strength | IC | molecular_function |
GO:0030198 | Extracellular matrix organization | TAS | biological_process |
GO:0030199 | Collagen fibril organization | IMP | biological_process |
GO:0030574 | Collagen catabolic process | TAS | biological_process |
GO:0030903 | Notochord development | IEA | biological_process |
GO:0042472 | Inner ear morphogenesis | IEA | biological_process |
GO:0042802 | Identical protein binding | NAS | molecular_function |
GO:0046872 | Metal ion binding | IEA | molecular_function |
GO:0048407 | Platelet-derived growth factor binding | IDA | molecular_function |
GO:0051216 | Cartilage development | TAS | biological_process |
GO:0060021 | Palate development | IEA | biological_process |
GO:0060174 | Limb bud formation | IEA | biological_process |
GO:0060272 | Embryonic skeletal joint morphogenesis | IMP | biological_process |
GO:0060351 | Cartilage development involved in endochondral bone morphogenesis | IEA | biological_process |
GO:0071599 | Otic vesicle development | IEA | biological_process |
GO:0071773 | Cellular response to BMP stimulus | IEA | biological_process |
GO:2001240 | Negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | IEA | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.7245818890 | 0.6593799096 | 0.9999902473 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Up | 0.0376060868 |
GSE13712_SHEAR | Up | 0.0225915126 |
GSE13712_STATIC | Up | 0.0383991868 |
GSE19018 | Up | 0.1942970441 |
GSE19899_A1 | Up | 0.0268250518 |
GSE19899_A2 | Up | 0.0530722915 |
PubMed_21979375_A1 | Down | -0.0536221790 |
PubMed_21979375_A2 | Down | -0.1095537890 |
GSE35957 | Up | 0.0885066892 |
GSE36640 | Down | -0.1093136424 |
GSE54402 | Down | -0.0914517092 |
GSE9593 | Down | -0.2455752659 |
GSE43922 | Down | -0.0122111154 |
GSE24585 | Up | 0.1821385450 |
GSE37065 | Down | -0.2814319075 |
GSE28863_A1 | Down | -0.0967304310 |
GSE28863_A2 | Down | -0.0371687538 |
GSE28863_A3 | Up | 0.4551148889 |
GSE28863_A4 | Up | 0.1361791284 |
GSE48662 | Down | -0.0482376498 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Name | Drug | Accession number |
---|---|---|
Collagenase clostridium histolyticum | DB00048 | BTD00010 | BIOD00010 |
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-106a-5p | MIMAT0000103 | MIRT048314 | CLASH | Functional MTI (Weak) | 23622248 |
Entries Per Page
Displaying Page of
- mirRecord
MicroRNA name | mirBase ID | Target site number | MiRNA mature ID | Test method inter | MiRNA regulation site | Reporter target site | Pubmed ID |
---|---|---|---|---|---|---|---|
hsa-miR-29a-3p | MIMAT0000086 | 1 | hsa-miR-29a | {Western blot} | {overexpression by miRNA mimics tranfection} | 21665270 | |
hsa-miR-29b-3p | MIMAT0000100 | 1 | hsa-miR-29b | {Western blot} | {overexpression by miRNA mimics tranfection} | 21665270 |
Entries Per Page
Displaying Page of
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 3 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
24658599 | The results were supported by data obtained from an AOM/DSS (azoxymethane/dextran sodium sulphate) colon cancer mouse model and from human colon cancer biopsy specimens colonised by pks+ E |
22454193 | The expression levels of mRNAs encoding aggrecan (ACAN), a major structural proteoglycan, type II collagen (COL2A1), and metalloproteinases (MMP) -1, -3, and -13, respectively, were determined using real-time PCR |
22454193 | RESULTS: Chondrocytes stimulated by IL-1beta showed increased MMP-1, MMP-3, and MMP-13 levels, whereas the expression of COL2A1 and ACAN decreased |
22454193 | However, in cells co-treated with IL-1beta and Rg3, the levels of MMP-1 and MMP-13 were lower than in cells treated with IL-1beta alone, and COL2A1 and ACAN expression levels recovered from the low values seen when cultured only in the presence of IL-1beta |
19747991 | INTRODUCTION: Once non-traumatic avascular necrosis of the femoral head (ANFH) happened, vascular impairment and feeble collateral circulation are followed by poor outcomes |
19747991 | We investigated whether abnormalities in EPCs levels and functions are present in ANFH patients |
19747991 | METHODS: 54 ANFH patients were enrolled, including steroid-induced (n=21), alcohol-induced (n=15) and idiopathic ANFH (n=18), and 30 healthy subjects as control (HC) |
19747991 | RESULTS: Mean numbers of circulating EPC were 1460+/-265 cells/ml in HC, 545+/-177 in ANFH, (P<0 |
19747991 | In addition, EPCs from ANFH patients showed reduced migratory capacity and increased cellular senescence compared with EPCs from normal subjects, furthermore the ability of angiogenesis in vitro was also impaired |
19747991 | CONCLUSION: Circulating endothelial progenitor cells (EPCs) numbers and functions are reduced in ANFH patients, suggesting that risk factors of ANFH may alter EPCs biology in angiogenesis and vascular repair |
Entries Per Page
Displaying Page of